Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-26T18:03:02.975Z Has data issue: false hasContentIssue false
  • English
  • Français

COST ANALYSIS OF INTRA PROCEDURAL RAPID ON SITE EVALUATION OF CYTOPATHOLOGY WITH ENDOBRONCHIAL ULTRASOUND

Published online by Cambridge University Press:  11 January 2016

Meena Kalluri ,
Lakshmi Puttagunta ,
Arto Ohinmaa ,
Nguyen Xuan Thanh  and
Eric Wong
Meena Kalluri
Affiliation:
Division of Respiratory Medicine, University of [email protected]
Lakshmi Puttagunta
Affiliation:
Pulmonary Research Group, University of Alberta Department of Laboratory Medicine and Pathology, University of Alberta
Arto Ohinmaa
Affiliation:
School of Public Health, University of Alberta
Nguyen Xuan Thanh
Affiliation:
School of Public Health, University of Alberta
Eric Wong
Affiliation:
Division of Respiratory Medicine, University of Alberta Pulmonary Research Group, University of Alberta
Get access Rights & Permissions [Opens in a new window]

Abstract

Background: Rapid on site evaluation (ROSE) allows immediate processing and interpretation of the aspirate in the procedural suite. It improves diagnostic yield and lowers patient care costs. There are limited data on its cost-effectiveness with endobronchial ultrasound (EBUS).

Methods: We developed an economic model with two arms, no ROSE (our current practice) and simulated ROSE. To simulate ROSE, a cytopathologist retrospectively identified the first diagnostic slide in each case. Using a decision analytic modeling technique under a hospital diagnostic unit perspective, the benefits of simulated ROSE were estimated as cost-savings. The model input was estimated from actual data, consulting experts, and the literature. The benefits were estimated as cost savings per patient and for the province of Alberta per year. Due to differences in the procedure, sarcoidosis and cancer patients were analyzed separately. The costs are shown in 2012 Canadian dollars, CAD.

Results: In our model without ROSE, the procedure cost/patient was CAD 646.00(USD 523.32) for cancer and CAD 1,170.00 (USD 947.73) for sarcoidosis. With simulated ROSE cost savings of CAD 63.00(37.00 to 89.00) [USD 51.04(29.97 to 72.10)], CAD 544.00(490.00 to 598.00) [USD 440.65(397.05 to 484.44)] for cancer and sarcoidosis, respectively. Extrapolating this to provincial data, our model estimates that EBUS with ROSE would lead to savings of CAD 50,000.00(30,000 to 71,000) [USD 40,501.24 (24,300.75 to 57,531.34)] for cancer and CAD 109,000.00 (87,000 to 130,000) [USD 88,337.07 (70,546.45 to 105,313.04) for sarcoidosis.

Conclusion: The use of ROSE with EBUS is cost saving. The projected savings were CAD 50,000.00 (USD 40,501.24) and CAD 109,000.00(USD 88,337.07) in cancer and sarcoidosis, respectively, for the province of Alberta, Canada.

Keywords

EBUSEndobronchial ultrasoundROSECost savingsLung cancerSarcoidosis
Type
Assessments
Information
International Journal of Technology Assessment in Health Care , Volume 31 , Issue 5 , 2015 , pp. 273 - 280
Copyright
Copyright © Cambridge University Press 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Drs. Kalluri and Wong designed the study, performed EBUS, collected data, and drafted the manuscript. Dr. Puttagunta reviewed all the slides retrospectively and helped review the manuscript. Drs. Ohinmaa and Nguyen developed the model and performed statistical analyses; they also drafted and reviewed the manuscript. The authors thank the MSI Foundation, Edmonton, for their grant support and Dr. Humaira Iqbal for her help with data collection and abstract preparation.

References

REFERENCES

1. Feller-Kopman, DJ, Brigham, E, Lechtzin, N, et al. Training perspective: The impact of starting an endobronchial ultrasound program at a major academic center on fellows training of transbronchial needle aspiration. Ann Am Thorac Soc. 2013;10:127–130.Google Scholar
2. Hurter, T, Hanrath, P. Endobronchial sonography: Feasibility and preliminary results. Thorax. 1992;47:565–567.Google Scholar
3. Jose, RJ, Shaw, P, Taylor, M, et al. Impact of EBUS-TBNA on modalities for tissue acquisition in patients with lung cancer. QJM. 2014;107:201–206.Google Scholar
4. Layfield, LJ, Bentz, JS, Gopez, EV. Immediate on-site interpretation of fine-needle aspiration smears: A cost and compensation analysis. Cancer. 2001;93:319–322.Google Scholar
5. Nakajima, T, Yasufuku, K, Yoshino, I. Current status and perspective of EBUS-TBNA. Gen Thorac Cardiovasc Surg. 2013;61:390–396.Google Scholar
6. Yasufuku, K, Pierre, A, Darling, G, et al. A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer. J Thorac Cardiovasc Surg. 2011;142:1393,400.e1.Google Scholar
7. Bruno, P, Ricci, A, Esposito, MC, et al. Efficacy and cost effectiveness of rapid on site examination (ROSE) in management of patients with mediastinal lymphadenopathies. Eur Rev Med Pharmacol Sci. 2013;17:1517–1522.Google Scholar
8. Schmidt, RL, Witt, BL, Matynia, AP, et al. Rapid on-site evaluation increases endoscopic ultrasound-guided fine-needle aspiration adequacy for pancreatic lesions. Dig Dis Sci. 2013;58:872–882.Google Scholar
9. Collins, BT, Chen, AC, Wang, JF, Bernadt, CT, Sanati, S. Improved laboratory resource utilization and patient care with the use of rapid on-site evaluation for endobronchial ultrasound fine-needle aspiration biopsy. Cancer Cytopathol. 2013;121:544–551.Google Scholar
10. Diacon, AH, Schuurmans, MM, Theron, J, et al. Utility of rapid on-site evaluation of transbronchial needle aspirates. Respiration. 2005;72:182–188.Google Scholar
11. Baram, D, Garcia, RB, Richman, PS. Impact of rapid on-site cytologic evaluation during transbronchial needle aspiration. Chest. 2005;128:869–875.Google Scholar
12. Clementsen, PF, Skov, BG, Vilmann, P, Krasnik, M. Endobronchial ultrasound-guided biopsy performed under optimal conditions in patients with known or suspected lung cancer may render mediastinoscopy unnecessary. J Bronchology Interv Pulmonol. 2014;21:21–25.Google Scholar
13. Trisolini, R, Cancellieri, A, Tinelli, C, et al. Rapid on-site evaluation of transbronchial aspirates in the diagnosis of hilar and mediastinal adenopathy: A randomized trial. Chest. 2011;139:395–401.Google Scholar
14. Fassina, A, Corradin, M, Zardo, D, et al. Role and accuracy of rapid on-site evaluation of CT-guided fine needle aspiration cytology of lung nodules. Cytopathology. 2011;22:306–312.Google Scholar
15. Jhala, NC, Eltoum, IA, Eloubeidi, MA, et al. Providing on-site diagnosis of malignancy on endoscopic-ultrasound-guided fine-needle aspirates: Should it be done? Ann Diagn Pathol. 2007;11:176–181.Google Scholar
16. National Cancer Institute. http://seer.cancer.gov/statfacts/html/lungb.html (accessed August 5, 2015).Google Scholar
17. Nakajima, T, Yasufuku, K, Kurosu, K, et al. The role of EBUS-TBNA for the diagnosis of sarcoidosis–Comparisons with other bronchoscopic diagnostic modalities. Respir Med. 2009;103:1796–800.Google Scholar
18. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/lung/statistics/?region = ab (accessed August 5, 2015).Google Scholar
19. Gu, P, Zhao, YZ, Jiang, LY, et al. Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: A systematic review and meta-analysis. Eur J Cancer. 2009;45:1389–1396.Google Scholar
20. Ost, DE, Ernst, A, Lei, X, et al. Diagnostic yield of endobronchial ultrasound-guided transbronchial needle aspiration: Results of the AQuIRE Bronchoscopy Registry. Chest. 2011;140:1557–1566.Google Scholar
21. Tremblay, A, Stather, DR, Maceachern, P, Khalil, M, Field, SK. A randomized controlled trial of standard vs endobronchial ultrasonography-guided transbronchial needle aspiration in patients with suspected sarcoidosis. Chest. 2009;136:340–346.Google Scholar
22. Bank of Canada. http://www.bankofcanada.ca/rates/related/inflation-calculator/?page_moved = 1 (accessed 2012).Google Scholar
23. Alberta population. http://finance.alberta.ca/aboutalberta/population-projections/2014--2041-alberta-population-projections.pdf (accessed 2014).Google Scholar
24. Sharples, LD, Jackson, C, Wheaton, E, et al. Clinical effectiveness and cost-effectiveness of endobronchial and endoscopic ultrasound relative to surgical staging in potentially resectable lung cancer: Results from the ASTER randomised controlled trial. Health Technol Assess. 2012;16:1–75, iii–iv.Google Scholar
25. Plit, ML, Havryk, AP, Hodgson, A, et al. Rapid cytological analysis of endobronchial ultrasound-guided aspirates in sarcoidosis. Eur Respir J. 2013;42:1302–1308.Google Scholar
26. Eapen, GA, Shah, AM, Lei, X, et al. Complications, consequences, and practice patterns of endobronchial ultrasound-guided transbronchial needle aspiration: Results of the AQuIRE registry. Chest. 2013;143:1044–1053.Google Scholar
27. Lee, JE, Kim, HY, Lim, KY, et al. Endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of lung cancer. Lung Cancer. 2010;70:51–56.Google Scholar
28. Griffin, AC, Schwartz, LE, Baloch, ZW. Utility of on-site evaluation of endobronchial ultrasound-guided transbronchial needle aspiration specimens. Cytojournal. 2011;8:20.Google Scholar
29. Joseph, M, Jones, T, Lutterbie, Y, et al. Rapid on-site pathologic evaluation does not increase the efficacy of endobronchial ultrasonographic biopsy for mediastinal staging. Ann Thorac Surg. 2013;96:403–410.Google Scholar
30. Schwartz, L, Yu, G, Baloch, Z. Rapid on-site evaluation of endobronchial ultrasound guided transbronchial needle aspiration: A practice to preserve or retire? Lab Invest. 2012;92:506.Google Scholar
31. Oki, M, Saka, H, Kitagawa, C, et al. Rapid on-site cytologic evaluation during endobronchial ultrasound-guided transbronchial needle aspiration for diagnosing lung cancer: A randomized study. Respiration. 2013;85:486–492.Google Scholar
32. Khurana, KK, Kovalovsky, A, Wang, D, Lenox, R. Feasibility of dynamic telecytopathology for rapid on-site evaluation of endobronchial ultrasound-guided transbronchial fine needle aspiration. Telemed J E Health. 2013;19:265–271.Google Scholar
33. Bonifazi, M, Sediari, M, Ferretti, M, et al. The role of the pulmonologist in rapid on-site cytologic evaluation of transbronchial needle aspiration: A prospective study. Chest. 2014;145:60–65.Google Scholar
34. Yarmus, L, Akulian, J, Gilbert, C, et al. Optimizing endobronchial ultrasound for molecular analysis. How many passes are needed? Ann Am Thorac Soc. 2013;10:636–643.Google Scholar
35. Bohm, J, Boisdur, L, Elze, M, et al. Improved lymph node staging of lung cancer using EBUSTBNAand liquid-based cytology: An alternative tomediastinoscopy? Onkologie. Conference: Jahrestagung der Deutschen, Osterreichischen und Schweizerischen Gesellschaften fur Hamatologie und Onkologie 2011 Basel Switzerland. 2011;34:149.Google Scholar
Supplementary material: File

Kalluri supplementary material

Figure S1

Download Kalluri supplementary material(File)
File 39.1 KB
Supplementary material: File

Kalluri supplementary material

Figure S2

Download Kalluri supplementary material(File)
File 65.5 KB
Supplementary material: File

Kalluri supplementary material

Figure S3

Download Kalluri supplementary material(File)
File 72.1 KB
Supplementary material: File

Kalluri supplementary material

Figure S4

Download Kalluri supplementary material(File)
File 69.8 KB
Supplementary material: File

Kalluri supplementary material

Figure S5

Download Kalluri supplementary material(File)
File 71.4 KB